Complete response of early gastric cancer to uracil and tegafur

被引：0
|
作者：
Kazuya Akahoshi
Yoshiharu Chijiiwa
Syuji Hamada
Keiichi Hara
Kazuhiko Nakamura
Hajime Nawata
Noriaki Matsui
机构：
[1] Third Department of Internal Medicine,
[2] Faculty of Medicine,undefined
[3] Kyushu University,undefined
[4] Fukuoka,undefined
[5] Japan,undefined
[6] Second Department of Pathology,undefined
[7] Faculty of Medicine,undefined
[8] Kyushu University,undefined
[9] Fukuoka,undefined
[10] Japan,undefined
来源：
Journal of Gastroenterology | 1998年 / 33卷
关键词：
Key words: early gastric cancer; UFT; complete response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A 74-year-old Japanese woman with early gastric cancer was successfully treated with uracil and tegafur (UFT). She was diagnosed by endoscopy (including endoscopic biopsy and endosonography) with an early gastric cancer, type IIa + IIc, on the greater curvature of the angulus. Surgical procedures or endoscopic therapy could not be performed because the patient had severe ischemic heart disease. Therefore, chemotherapy with UFT was administered at 300 mg/day for 15 months. Follow-up endoscopy, endosonography, and biopsy showed disappearance of the gastric cancer. To our knowledge, this is the first case report of the complete response of an early gastric cancer to UFT in the English-language literature.
引用
收藏
页码：864 / 867
页数：3
相关论文
共 50 条
  • [41] The role of uracil-tegafur (UFT) in elderly patients with colorectal cancer
    Labianca, R
    Beretta, GD
    Mosconi, S
    Milesi, L
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 73 - 80
  • [42] Tegafur-uracil as palliative chemotherapy in refractory locally advanced or metastatic gastric cancer: A Brazilian single center experience
    Beato, C.
    Ismael, G.
    Coradazzi, A.
    Cantarelli, A.
    Andrade, A.
    Passeri, C.
    Prado, A.
    Segalla, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 91 - 91
  • [43] A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma
    Woo, IS
    Moon, DH
    Shim, BY
    Lee, MA
    Byun, JH
    Kim, KW
    Kang, JH
    Choi, MG
    Chung, IS
    Hong, YS
    Park, SY
    Lee, KS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (01) : 13 - 17
  • [44] Oral Tegafur/Uracil: profile report
    Drugs & Therapy Perspectives, 2002, 18 (7) : 5 - 6
  • [45] The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
    J Almond
    S Ralston
    British Journal of Cancer, 2007, 96 : 1489 - 1489
  • [46] A COOPERATIVE RANDOMIZED STUDY ON TEGAFUR PLUS MITOMYCIN-C VERSUS COMBINED TEGAFUR AND URACIL PLUS MITOMYCIN-C IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    KURIHARA, M
    IZUMI, T
    YOSHIDA, S
    OHKUBO, T
    SUGA, S
    KIYOHASHI, A
    YAOSAKA, T
    TAKAHASHI, H
    ITO, T
    SASAI, T
    AKIYA, T
    AKAZAWA, S
    BETSUYAKU, T
    TAGUCHI, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (05): : 613 - 620
  • [47] EFFECT OF COADMINISTRATION OF URACIL ON THE TOXICITY OF TEGAFUR
    YAMAMOTO, J
    HARUNO, A
    YOSHIMURA, Y
    UNEMI, N
    KUNIMUNE, Y
    YAMASHITA, K
    MORITA, K
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (02) : 212 - 214
  • [48] The role of tegafur/uracil in pulmonary malignancy
    Langer, CJ
    DRUGS, 1999, 58 (Suppl 3) : 71 - 75
  • [49] The Role of Tegafur/Uracil in Pulmonary Malignancy
    Corey J. Langer
    Drugs, 1999, 58 : 71 - 75
  • [50] Complete response of metastatic gastric cancer to chemoimmunotherapy
    Ina, Kenji
    Furuta, Ryuichi
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 140 - 140
12345